M&A Deal Summary |
|
---|---|
Date | 2023-06-12 |
Target | Adenza |
Sector | Software |
Buyer(s) | Nasdaq |
Sellers(s) | Thoma Bravo |
Deal Type | Add-on Acquisition |
Deal Value | 10.5B USD |
Advisor(s) | Qatalyst Partners Barclays Investment Bank Citigroup Investment Banking Evercore Group HSBC Global Banking and Markets Jefferies Piper Sandler & Co. (Financial) Kirkland & Ellis (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1971 |
Sector | Financial Services |
Employees | 6,377 |
Revenue | 741M USD (2023) |
Nasdaq is an exchange company. With over 3,900 listed companies, it delivers trading, exchange technology and public company services across six continents. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market; the OMX Nordic Exchange, including First North; and the 144A PORTAL Market. Nasdaq was founded in 1971 and is based in New York City.
DEAL STATS | # |
---|---|
Overall | 30 of 30 |
Sector (Software) | 5 of 5 |
Type (Add-on Acquisition) | 23 of 23 |
State (New York) | 5 of 5 |
Country (United States) | 16 of 16 |
Year (2023) | 1 of 1 |
Size (of disclosed) | 1 of 8 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-06-02 |
Metrio
Montreal, Quebec, Canada Metrio is a provider of environmental, social, and governance (ESG) data collection, analytics, and reporting services. The Company's CSR reporting software has helped more than 5,000 users at over 100 global companies simplify the way they collect, analyze, and share their ESG data to become more sustainable, transparent, and profitable. Metrio was founded in 2009 and is based in Montreal, Quebec. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-02-01 |
Nasdaq Salmon Index
United States Nasdaq Salmon Index serving as a price reference for physical contracts and as a tool for analysts, academia, investors, and banks. |
Sell | - |
Category | Private Equity Firm |
---|---|
Founded | 1980 |
PE ASSETS | 127.0B USD |
Size | Mega |
Type | Sector Agnostic |
Thoma Bravo is a private equity firm that primarily invests in or acquires US-based middle-market businesses. While Thoma Bravo will consider a variety of transaction situations, including take-privates, buyouts, carve-outs, recapitalizations, and growth equity financings, the Firm has a special interest in tech consolidation opportunities. Target companies generally have a history of profitability with EBITDA of at least $20 million. The Firm's equity commitment size range is $100 to $750 million. Sectors of interest include enterprise and infrastructure software, education, distribution, financial services and consumer goods/services. The Firm will not invest in new inventions or technologies, developmental products or services, start-ups, biotech, motion pictures, distressed businesses, oil/gas, or real estate. Thoma Bravo was formerly known as Thoma Cressey Bravo and before that Golder Thoma & Co. The Firm was originally formed in 1980 and is based in Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 70 of 79 |
Sector (Software) | 31 of 33 |
Type (Add-on Acquisition) | 31 of 36 |
State (New York) | 2 of 3 |
Country (United States) | 65 of 73 |
Year (2023) | 2 of 6 |
Size (of disclosed) | 2 of 23 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-01-20 |
Magnet Forensics
Waterloo, Ontario, Canada Magnet Forensics is a developer of digital investigation software that acquires, analyzes, reports on, and manages evidence from digital sources, including computers, mobile devices, IoT devices, and cloud services. Its software is used by more than 4,000 public and private sector customers in over 90 countries and helps investigators fight crime, protect assets and guard national security. Magnet Forensics was founded in 2010 and is headquartered in Waterloo, Ontario. |
Buy | CA$1.8B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-07-17 |
Bluesight
Alexandria, Virginia, United States Bluesight solves supply chain inefficiencies and reduces risk by using AI and machine learning to surface actionable analytics for every step of the medication lifecycle. Bluesight is based in Alexandria, Virginia. |
Buy | - |